Philadelphia chromosome-positive T-cell acute lymphoblastic leukemia: a case report

J Int Med Res. 2024 Feb;52(2):3000605231156757. doi: 10.1177/03000605231156757.

Abstract

Philadelphia chromosome-positive (Ph+) T-cell acute lymphoblastic leukemia (T-ALL) is a rare and aggressive type of acute leukemia. The Philadelphia chromosome is the hallmark of chronic myeloid leukemia (CML). The differentiation between Ph+ T-ALL and T-cell lymphoblastic crisis of CML may be problematic in some cases. Here, we report a rare case of de novo Ph+ T-ALL that presented a diagnostic challenge. The overall clinical, immunophenotypic, cytogenetic, and xenotransplantation results suggest a diagnosis of Ph+ T-ALL. The patient was treated with induction chemotherapy including imatinib followed by haploidentical stem cell transplantation and achieved complete remission.

Keywords: BCR-ABL1; Philadelphia chromosome; T-cell acute lymphoblastic leukemia; case report; chronic myeloid leukemia; diagnosis.

Publication types

  • Case Reports

MeSH terms

  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
  • Philadelphia Chromosome
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / diagnosis
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / therapy
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / diagnosis
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / genetics
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / therapy
  • T-Lymphocytes